As celebrity lookalike contests continue to surge in popularity, Brittany Miller attends the latest Pedro Pascal-themed ...

The ultimate aim of the collaboration is to build a single cell reference map that will enable virtual cell modeling and potentially help predict the effect of drugs in cancer patients – where ...

The Wellcome Sanger Institute, Parse Biosciences, and the Computational Health Center at Helmholtz Munich today announced a collaboration to build the foundation of a single cell atlas, focused on ...

The Wellcome Sanger Institute, Parse Biosciences, and the Computational Health Center at Helmholtz Munich today announced a collaboration to build the foundation of a single cell atlas, focused on und ...

President Donald Trump lashed out at Michael Wolff, the biographer who made the claim and has written about the president ...

MBX Biosciences offers a unique prodrug approach with three promising candidates targeting hypoparathyroidism, post-bariatric hypoglycemia, and obesity - two of its three drug candidates are GLP ...

HAMILTON, Mont. – Scientists are often careful to take off their work badges when they leave the campus of one of the nation’s top research facilities, here in southwestern Montana’s ...

Castle Biosciences, Inc. will present innovative research on cutaneous melanoma (CM) and uveal melanoma (UM) at the 2025 ASCO Annual Meeting in Chicago, showcasing findings from a collaboration ...

Pacific Biosciences of California (PACB) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most ...

Pacira BioSciences reported $168.9 million in sales and about $2 million in operating profit for the Q1:2025. Pacira BioSciences, Inc. reported $168.9 million in sales and about $2 million in ...

--(BUSINESS WIRE)--#Biomarkers--Octave Bioscience, Inc., a leading precision care company that is delivering a new standard for managing multiple sclerosis (MS) and other neurodegenerative diseases, ...

In the preceding three months, 4 analysts have released ratings for Cytek Biosciences CTKB, presenting a wide array of perspectives from bullish to bearish. Summarizing their recent assessments ...